US 11,052,023 B2
Drug delivery device having controlled delivery and confirmation
Noel C. Codella, Yorktown Heights, NY (US); Jonathan H. Connell, II, Cortlandt-Manor, NY (US); Sharathchandra Pankanti, Darien, CT (US); and Nalini K. Ratha, Yorktown Heights, NY (US)
Assigned to International Business Machines Corporation, Armonk, NY (US)
Filed by International Business Machines Corporation, Armonk, NY (US)
Filed on Dec. 20, 2017, as Appl. No. 15/848,169.
Prior Publication US 2019/0183732 A1, Jun. 20, 2019
Int. Cl. A61J 3/07 (2006.01); G16H 20/10 (2018.01); A61K 9/48 (2006.01); A61K 9/20 (2006.01); G16H 10/60 (2018.01); A61B 5/145 (2006.01); A61B 5/00 (2006.01); A61B 5/07 (2006.01); A61M 31/00 (2006.01); G16H 10/20 (2018.01)
CPC A61J 3/07 (2013.01) [A61B 5/073 (2013.01); A61B 5/14507 (2013.01); A61B 5/14539 (2013.01); A61B 5/6861 (2013.01); A61B 5/6873 (2013.01); A61K 9/2072 (2013.01); A61K 9/4808 (2013.01); G16H 10/60 (2018.01); G16H 20/10 (2018.01); A61B 5/07 (2013.01); A61B 5/4833 (2013.01); A61B 5/6885 (2013.01); A61B 2503/08 (2013.01); A61B 2505/07 (2013.01); A61M 31/002 (2013.01); G16H 10/20 (2018.01)] 10 Claims
OG exemplary drawing
 
1. A drug delivery device comprising:
a capsule comprising a first portion and a second portion fitting at least partially inside the first portion;
a logic circuit disposed within the capsule;
an actuator connected to the logic circuit and configured to expose an interior of the capsule to an exterior of the capsule upon activation by the logic circuit;
a resilient member, wherein the first portion and the second portion enclose the resilient member, and wherein the resilient member applies a force against the first portion and the second portion; and
a fiber securing the first portion and the second portion together, wherein the actuator is configured to release the fiber, enabling the resilient member to separate the first portion from the second portion.